PA
AMGN icon

Pineridge Advisors’s Amgen AMGN Stock Holding History

Pineridge Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.37K Hold
15
– – ﹤0.01% 287
2025
Q2 		$4.29K Hold
15
– – ﹤0.01% 327
2025
Q1 		$4.76K Hold
15
– – ﹤0.01% 313
2024
Q4 		$3.96K Hold
15
– – ﹤0.01% 414
2024
Q3 		$4.86K Hold
15
– – ﹤0.01% 347
2024
Q2 		$4.69K Sell
15
-5
-25% -$1.47K ﹤0.01% 375
2024
Q1 		$5.71K Sell
20
-2
-9% -$585 ﹤0.01% 346
2023
Q4 		$6.35K Buy
+22
New +$5.99K ﹤0.01% 450

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pineridge Advisors's AMGN Position: Q3 2025 in Review

Pineridge Advisors held its Amgen (AMGN) position steady in Q3 2025 at 15 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Pineridge Advisors first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $6.35K in Q4 2023. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Pineridge Advisors held 15 shares of Amgen worth $4.37K as of Q3 2025.
  • Pineridge Advisors left its Amgen share count unchanged in Q3 2025.
  • Amgen made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #287 holding.
  • Pineridge Advisors first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's Amgen position peaked at $6.35K in Q4 2023.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.